These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38322311)

  • 41. Retrobulbar Amphotericin B Injection in Curbing the Progression of COVID Associated Rhino-orbital Cerebral Mucormycosis: A Retrospective Case Series.
    Pathak M; Sahu V; Arora RD; Shambharkar MM; Naveen P; Pati SK; Nagarkar NM
    Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):3352-3358. PubMed ID: 36246726
    [No Abstract]   [Full Text] [Related]  

  • 42. Alternating pattern of rhino-orbital-cerebral mucormycosis with COVID-19 in diabetic patients.
    Eker C; Tarkan O; Surmelioglu O; Dagkiran M; Tanrisever I; Yucel Karakaya SP; Ulas B; Onan E; Uguz AH; Ozdemir S
    Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):219-226. PubMed ID: 35768700
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sinonasal mucormycosis and liposomal amphotericin B: A quest for dose optimization.
    Kajal S; Naeem SS; Gupta P; Kairo AK; Ahmed A; Verma P; Saini A
    Indian J Pharmacol; 2022; 54(2):90-96. PubMed ID: 35546459
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Orbital exenteration: A dilemma in mucormycosis presented with orbital apex syndrome.
    Songu M; Unlu HH; Gunhan K; Ilker SS; Nese N
    Am J Rhinol; 2008; 22(1):98-103. PubMed ID: 18284868
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients.
    Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA
    Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Survival in rhino-orbito-cerebral mucormycosis: An international, multicenter ID-IRI study.
    Cag Y; Erdem H; Gunduz M; Komur S; Ankarali H; Ural S; Tasbakan M; Tattevin P; Tombak A; Ozturk-Engin D; Tartar AS; Batirel A; Tekin R; Duygu F; Caskurlu H; Kurtaran B; Durdu B; Haciseyitoglu D; Rello J;
    Eur J Intern Med; 2022 Jun; 100():56-61. PubMed ID: 35304041
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Successful treatment of rhino-orbital mucormycosis without exenteration: the use of multiple treatment modalities.
    Pelton RW; Peterson EA; Patel BC; Davis K
    Ophthalmic Plast Reconstr Surg; 2001 Jan; 17(1):62-6. PubMed ID: 11206749
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rhino-orbital mucormycosis: Our experiences with clinical features and management in a tertiary care center.
    Singh SP; Rana J; Singh VK; Singh R; Sachan R; Singh S; Jain S
    Rom J Ophthalmol; 2021; 65(4):339-353. PubMed ID: 35087975
    [No Abstract]   [Full Text] [Related]  

  • 49. Retrobulbar Injection of Amphotericin B in Patients With COVID-19 Associated Orbital Mucormycosis: A Systematic Review.
    Sharifi A; Akbari Z; Shafie'ei M; Nasiri N; Sharifi M; Shafiei M; Zand A
    Ophthalmic Plast Reconstr Surg; 2022 Sep-Oct 01; 38(5):425-432. PubMed ID: 35943425
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rhino-Orbital Cerebral Mucormycosis in a Non-diabetic Patient Following COVID-19 Infection: A Case Report and Literature Review.
    Niazi M; Vittorino I; Thwe H; Alam B; Awosika AO; Omole AE
    Cureus; 2022 Dec; 14(12):e32884. PubMed ID: 36699798
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes.
    Nithyanandam S; Jacob MS; Battu RR; Thomas RK; Correa MA; D'Souza O
    Indian J Ophthalmol; 2003 Sep; 51(3):231-6. PubMed ID: 14601848
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Post-COVID-19 rhino-orbito-cerebral mucormycosis: a new addition to challenges in pandemic control.
    Mitra S; Janweja M; Sengupta A
    Eur Arch Otorhinolaryngol; 2022 May; 279(5):2417-2422. PubMed ID: 34309754
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A meta-analysis of survival factors in rhino-orbital-cerebral mucormycosis-has anything changed in the past 20 years?
    Vaughan C; Bartolo A; Vallabh N; Leong SC
    Clin Otolaryngol; 2018 Dec; 43(6):1454-1464. PubMed ID: 29947167
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Successful treatment of rhino-orbital mucormycosis by a new combination therapy with liposomal amphotericin B and micafungin.
    Ogawa T; Takezawa K; Tojima I; Shibayama M; Kouzaki H; Ishida M; Okabe H; Shimizu T
    Auris Nasus Larynx; 2012 Apr; 39(2):224-8. PubMed ID: 21592699
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Battling the emerging epidemic of rhino-orbital-cerebral mucormycosis (ROCM) in COVID-19 pandemic: an interventional study.
    Gandhi A; Narula A; Chandra S; Agarwal D; Mehta A; Nayak S; Arora S; Capoor MR
    Int Ophthalmol; 2023 May; 43(5):1571-1580. PubMed ID: 36273362
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mucormycosis in post-covid patients: An epidemic in pandemic.
    Kesarwani V; Kumar A; Kesarwaani S; Kesarwani D
    J Family Med Prim Care; 2022 Jun; 11(6):3368-3371. PubMed ID: 36119254
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Surgical & medical management of ROCM (Rhino-orbito-cerebral mucormycosis) epidemic in COVID-19 era and its outcomes - a tertiary care center experience.
    Soni K; Das A; Sharma V; Goyal A; Choudhury B; Chugh A; Kumar D; Yadav T; Jain V; Agarwal A; Garg M; Bhatnagar K; Elhence P; Bhatia PK; Garg MK; Misra S
    J Mycol Med; 2022 May; 32(2):101238. PubMed ID: 34979299
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rise of the phoenix: Mucormycosis in COVID-19 times.
    Ravani SA; Agrawal GA; Leuva PA; Modi PH; Amin KD
    Indian J Ophthalmol; 2021 Jun; 69(6):1563-1568. PubMed ID: 34011742
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early Differential Diagnosis of Rhino-Orbito-Cerebral Mucormycosis and Bacterial Orbital Cellulitis: Based on Computed Tomography Findings.
    Son JH; Lim HB; Lee SH; Yang JW; Lee SB
    PLoS One; 2016; 11(8):e0160897. PubMed ID: 27501044
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rhino-orbital Mucormycosis: Clinical Findings and Treatment Outcomes of Four Cases.
    Karadeniz Uğurlu Ş; Selim S; Kopar A; Songu M
    Turk J Ophthalmol; 2015 Aug; 45(4):169-174. PubMed ID: 27800226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.